Multidisciplinary Prerounding Meeting as a Continuous Quality Improvement Tool: Leveraging to Reduce Continuous Benzodiazepine Use at an Academic Medical Center.


Journal

Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 24 4 2018
medline: 24 1 2020
entrez: 24 4 2018
Statut: ppublish

Résumé

Evidence-based medicine often has many barriers to overcome prior to implementation in practice, hence the importance of continuous quality improvement. We report on a brief (≤10 minutes) multidisciplinary meeting prior to rounds to establish a dashboard for continuous quality improvement and studied the success of this meeting on a particular area of focus: continuous infusion benzodiazepine minimization. This was a prospective observational study of patients admitted to the medical intensive care unit (MICU) of a large academic medical center over a 4-month period. A morning multidisciplinary prerounding meeting was implemented to report on metrics required to establish a dashboard for MICU care for the previous 24 hours. Fellows and nurse practitioners on respective teams reported on key quality metrics and other important data related to patient census. Continuous benzodiazepines were tracked daily as the number of patients per team who had orders for a continuous benzodiazepine infusion. The aim of this report is to describe the development of the morning multidisciplinary prerounding meeting and its impact on continuous benzodiazepine use, along with associated clinical outcomes. The median number of patients prescribed a continuous benzodiazepine daily decreased over this time period and demonstrated a sustained reduction at 1 year. Furthermore, sedation scores improved, corresponding to a reduction in median duration of mechanical ventilation. The effectiveness of this intervention was mapped post hoc to conceptual models used in implementation science. A brief multidisciplinary meeting to review select data points prior to morning rounds establishes mechanisms for continuous quality improvement and may serve as a mediating factor for successful implementation when initiating and monitoring practice change in the ICU.

Sections du résumé

BACKGROUND BACKGROUND
Evidence-based medicine often has many barriers to overcome prior to implementation in practice, hence the importance of continuous quality improvement. We report on a brief (≤10 minutes) multidisciplinary meeting prior to rounds to establish a dashboard for continuous quality improvement and studied the success of this meeting on a particular area of focus: continuous infusion benzodiazepine minimization.
METHODS METHODS
This was a prospective observational study of patients admitted to the medical intensive care unit (MICU) of a large academic medical center over a 4-month period. A morning multidisciplinary prerounding meeting was implemented to report on metrics required to establish a dashboard for MICU care for the previous 24 hours. Fellows and nurse practitioners on respective teams reported on key quality metrics and other important data related to patient census. Continuous benzodiazepines were tracked daily as the number of patients per team who had orders for a continuous benzodiazepine infusion. The aim of this report is to describe the development of the morning multidisciplinary prerounding meeting and its impact on continuous benzodiazepine use, along with associated clinical outcomes.
RESULTS RESULTS
The median number of patients prescribed a continuous benzodiazepine daily decreased over this time period and demonstrated a sustained reduction at 1 year. Furthermore, sedation scores improved, corresponding to a reduction in median duration of mechanical ventilation. The effectiveness of this intervention was mapped post hoc to conceptual models used in implementation science.
CONCLUSIONS CONCLUSIONS
A brief multidisciplinary meeting to review select data points prior to morning rounds establishes mechanisms for continuous quality improvement and may serve as a mediating factor for successful implementation when initiating and monitoring practice change in the ICU.

Identifiants

pubmed: 29683053
doi: 10.1177/0885066618769015
doi:

Substances chimiques

Benzodiazepines 12794-10-4

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-713

Subventions

Organisme : British Heart Foundation
ID : RG/12/12/29872
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700320
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K003232/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/C503646/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/16/33294
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600785
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R01065X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000458
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/11/45/28859
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R01065X/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L009684/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/10/98/28655
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023150/2
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/26/31373
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/13/13/30018
Pays : United Kingdom
Organisme : British Heart Foundation
ID : IG/16/2/32273
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/44/33064
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023150/1
Pays : United Kingdom

Auteurs

Alexander H Flannery (AH)

1 Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
2 Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA.

Melissa L Thompson Bastin (ML)

1 Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
2 Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA.

Ashley Montgomery-Yates (A)

3 University of Kentucky College of Medicine, Lexington, KY, USA.

Corrine Hook (C)

3 University of Kentucky College of Medicine, Lexington, KY, USA.

Evan Cassity (E)

3 University of Kentucky College of Medicine, Lexington, KY, USA.

Phillip M Eaton (PM)

4 Internal Medicine, University of Kentucky HealthCare, Lexington, KY, USA.

Peter E Morris (PE)

3 University of Kentucky College of Medicine, Lexington, KY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH